Endocrine Technology, LLC has approved patents in both USA and India for "Immune Modulation" sciences. Our primary work is focussing on research and development to find and develop new therapeutic applications and filing patents for them. This year in 2023, we have filed for
following new patents
1. Cancer "second generation Immune check Point Inhibitor"
2. Prophylaxis and Therapy of Blindness
3. We have submitted 12 new Abstracts in "Major Life threatening diseases published as abstracts in Boston Conference "FOCIS" 2023